The Endocrine Society now issued a Clinical Practice Guideline (CPG) advising against the usage of testosterone therapy in healthy women. Although the FDA approved testosterone therapy for the treatment of diseases involving the testes, pituitary and hypothalamus, it has not been approved for treating age-associated declines in testosterone levels
. The U.S. National Institute on Aging is also expected to release the results of research on the security of testosterone. The study involved about 800 older men with low testosterone and symptoms related to this condition, for example testosterone therapy cost australia (tinyurl.com
) sexual and physical dysfunction. The research is anticipated to shed more light on the security of testosterone treatment since the heart health of the men was carefully monitored.
The recent conflicting findings on testosterone therapy prompted Patel and his team to conduct a substantial systematic literature search for studies evaluating the relationship between testosterone replacement therapy and cardiovascular events among guys. An estimated 13 million men in the USA suffer from low testosterone, which occurs when the body fails to make enough hormones because of a difficulty with the testicles or pituitary gland. This explains an individual's unexpected weight gain, obvious aging and decline
And many women have a knee jerk feeling that any hormone treatment can raise their risk of breast cancer. However, clinical studies demonstrate that testosterone not only does not raise a woman's risk of breast cancer , it may play a key role in warding off the disease. Glaser believes this will probably stay the status quo for a while, given the prohibitive cost of conducting the long term safety studies needed to gain more total FDA acceptance.